NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054603

Registered date:13/06/2024

The role of allopregnanolone in postpartum depression

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedpostpartum depression
Date of first enrollment2024/06/30
Target sample size50
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeSerum concentrations of progesterone metabolites (pregnenolone, progesterone, 5alpha-dihydroprogesterone, allopregnanolone) at late pregnancy (around 36 weeks of pregnancy), immediately after delivery (3-6 days after delivery), 3 months and 5 months after delivery, when postpartum depression is most likely to occur. Edinburgh Postnatal Depression Questionnaire(EPDS), Athens Insomnia Scale(AIS), and Brief-type self-administered diet history questionnaire (BDHQ) at the same time points.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderFemale
Include criteria
Exclude criteriaThose who do not consent to informed consent.

Related Information

Contact

public contact
Name Asuka Hirose
Address Yushima 1-5-45, Bunkyo, Tokyo Japan 113-8510
Telephone 03-5803-5322
E-mail a-kacrm@tmd.ac.jp
Affiliation Tokyo Medical and Dental University Department of Obstetrics and Gynecology
scientific contact
Name Asuka Hirose
Address Yushima 1-5-45, Bunkyo, Tokyo Japan
Telephone 03-5803-5322
E-mail a-kacrm@tmd.ac.jp
Affiliation Tokyo Medical and Dental University Department of Obstetrics and Gynecology